StonvexLoading…
StonvexStonvexStonvexCore line items from VABK's most recent SEC filings (10-K / 10-Q via EDGAR XBRL). Last 4 reporting periods.
Quarterly filings sourced directly from SEC EDGAR. Real-time earnings actuals are in the Earnings panel above.
| Metric | Q1 2026 2026-03-31 | Annual 2025 2025-12-31 | Q3 2025 2025-09-30 | Q2 2025 2025-06-30 |
|---|---|---|---|---|
Revenue | $18.88M | $77.25M | $57.61M | $38.14M |
Operating Income | $6.53M | $24.08M | $16.50M | $10.81M |
Net Income | $5.26M | $19.26M | $13.30M | $4.24M |
EPS (Diluted) | $0.97 | $3.55 | $2.45 | $1.61 |
Total Assets | $1.65B | $1.65B | $1.61B | $1.63B |
Total Liabilities | $1.46B | $1.47B | $1.43B | $1.46B |
Cash & Equivalents | Not available | Not available | Not available | Not available |
Free Cash Flow OCF − CapEx | $7.04M | $20.75M | $14.59M | $8.54M |
Shares Outstanding | 5.42M | 5.39M | 5.39M | 5.39M |